Skip to content

PHARMACIE MINGNEAU: what changed

What changed

PHARMACIE MINGNEAU

BE 0443.686.314
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€80,038
2024 · €25,953+€54,085
Equity
€244,197
2024 · €164,159+€80,038
Cash
€110,790
2024 · €51,266+€59,524
Balance sheet total
€1.9m
2024 · €1.8m+€62,598

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€82,176

    down €82,176 (-5.3%), from €1.6m to €1.5m

  • Cash +€59,524

    up €59,524 (+116%), from €51,266 to €110,790

    mainly Depreciation (+€97,920) and Net result for the year (+€80,038)

  • Stocks and contracts +€56,865

    up €56,865 (+42.3%), from €134,488 to €191,353

  • Receivables within one year +€28,390

    up €28,390 (+41.8%), from €67,928 to €96,318

    of which Other amounts receivable: +€16,050

Equity and liabilities
  • Current portion of long-term debt -€152,517

    down €152,517 (-61.4%), from €248,424 to €95,908

  • Reserves +€80,038

    up €80,038 (+1,291%), from €6,200 to €86,238

    of which Distributable reserves: +€80,038

  • Debts after one year +€59,092

    up €59,092 (+4.6%), from €1.3m to €1.3m

  • Trade debts +€46,624

    up €46,624 (+76.0%), from €61,329 to €107,952

  • Tax, wage and social debts +€27,663

    up €27,663 (+135%), from €20,415 to €48,078

    of which Taxes: +€21,727

Income statement
  • Gross operating margin +€90,641

    up €90,641 (+28.6%), from €317,437 to €408,078

  • Taxes +€28,344

    up €28,344 (+6,883%), from €412 to €28,756

  • Other operating charges +€4,176

    up €4,176 (+24.2%), from €17,225 to €21,401

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €25,953
Gross operating margin +€90,641
Staff costs +€1,598
Depreciation -€2,680
Write-downs -€2,369
Other operating charges -€4,176
Financial income +€48
Financial charges -€633
Taxes -€28,344
Result 2025 €80,038
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€168,693
Investment -€15,745
Financing -€93,424
Cash 2024 €51,266
Net result for the year +€80,038
Depreciation +€97,920
Stocks and contracts -€56,865
Receivables within one year -€28,390
Deferred charges and accrued income +€5
Trade debts +€46,624
Tax, wage and social debts +€27,663
Other debts +€1,698
Investment in fixed assets (net) -€15,745
Debts after one year +€59,092
Current portion of long-term debt -€152,517
Cash 2025 €110,790
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,806,718 €1,869,315 +€62,598 +3.5%
Fixed assets 21/28 €1,551,633 €1,469,457 -€82,176 -5.3%
Tangible fixed assets 22/27 €1,551,633 €1,469,457 -€82,176 -5.3%
Land and buildings 22 €1,092,073 €1,051,499 -€40,575 -3.7%
Plant, machinery and equipment 23 €451,058 €411,417 -€39,641 -8.8%
Furniture and vehicles 24 €8,502 €6,542 -€1,960 -23.0%
Current assets 29/58 €255,085 €399,858 +€144,773 +56.8%
Stocks and contracts in progress 3 €134,488 €191,353 +€56,865 +42.3%
Stocks 30/36 €134,488 €191,353 +€56,865 +42.3%
Amounts receivable within one year 40/41 €67,928 €96,318 +€28,390 +41.8%
Trade receivables 40 €66,330 €78,670 +€12,340 +18.6%
Other amounts receivable 41 €1,598 €17,648 +€16,050 +1,004%
Cash at bank and in hand 54/58 €51,266 €110,790 +€59,524 +116%
Deferred charges and accrued income 490/1 €1,402 €1,397 -€5 -0.4%
Total equity and liabilities 10/49 €1,806,718 €1,869,315 +€62,598 +3.5%
Equity 10/15 €164,159 €244,197 +€80,038 +48.8%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €6,200 €86,238 +€80,038 +1,291%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 - €80,038 +€80,038
Profit (loss) carried forward 14 €95,959 €95,959 = 0.0%
Amounts payable 17/49 €1,642,559 €1,625,118 -€17,440 -1.1%
Amounts payable after more than one year 17 €1,271,847 €1,330,940 +€59,092 +4.6%
Financial debts 170/4 €1,271,847 €1,330,940 +€59,092 +4.6%
Amounts payable within one year 42/48 €370,711 €294,179 -€76,532 -20.6%
Current portion of amounts payable after more than one year 42 €248,424 €95,908 -€152,517 -61.4%
Trade debts 44 €61,329 €107,952 +€46,624 +76.0%
Suppliers 440/4 €61,329 €107,952 +€46,624 +76.0%
Taxes, remuneration and social security 45 €20,415 €48,078 +€27,663 +135%
Taxes 450/3 €8,897 €30,624 +€21,727 +244%
Remuneration and social security 454/9 €11,519 €17,454 +€5,936 +51.5%
Other amounts payable 47/48 €40,543 €42,240 +€1,698 +4.2%
Remuneration, social security and pensions 62 €139,192 €137,594 -€1,598 -1.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €95,240 €97,920 +€2,680 +2.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€146 €2,223 +€2,369
Other operating charges 640/8 €17,225 €21,401 +€4,176 +24.2%
Gross operating margin 9900 €317,437 €408,078 +€90,641 +28.6%
Operating profit (loss) 9901 €65,926 €148,940 +€83,014 +126%
Financial income 75/76B €69 €117 +€48 +70.5%
Recurring financial income 75 €69 €117 +€48 +70.5%
Financial charges 65/66B €39,630 €40,263 +€633 +1.6%
Recurring financial charges 65 €39,630 €40,263 +€633 +1.6%
Profit (loss) for the period before taxes 9903 €26,364 €108,794 +€82,430 +313%
Income taxes 67/77 €412 €28,756 +€28,344 +6,883%
Profit (loss) for the period 9904 €25,953 €80,038 +€54,085 +208%
Profit (loss) for the period to be appropriated 9905 €25,953 €80,038 +€54,085 +208%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.